Article Details

Immunovant (NASDAQ:IMVT) Shares Up 7.7% - The AM Reporter

Retrieved on: 2022-09-10 17:37:02

Tags for this article:

Click the tags to see associated articles and topics

Immunovant (NASDAQ:IMVT) Shares Up 7.7% - The AM Reporter. View article details on hiswai:

Excerpt

It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up